Literature DB >> 7328581

Membrane effects of antiinflammatory agents. 2. Interaction of nonsteroidal antiinflammatory drugs with liposome and purple membranes.

S B Hwang, T Y Shen.   

Abstract

The interaction of the nonsteroidal antiinflammatory drugs (NSAIDS) indomethacin, diflunisal, and flurbiprofen and the active sulfide metabolite of sulindac with phosphatidylcholine (PC) liposomes was investigated using differential scanning calorimetry (DSC). These biologically active structures decrease the phase transition temperature and broaden the transition peak with increasing concentration, but without affecting the enthalpy change for the transition on the thermal scan. A comparison with the effects of the prodrug sulindac and its inactive sulfone metabolite suggests that the main action of NSAIDS on membranes is a reduction of the cooperative interaction between phospholipid molecules. The probable positions of these compounds in the bilayer are inferred from similar DSC effects of several reference compounds whose mode of binding to the PC bilayer have previously been described. The active antiinflammatory structures appear to insert deeply into the hydrocarbon region of the bilayer, whereas the inactive compounds probably bind mainly to the carbonyl region near the surface. Using purple membrane as a model to study the drug effect on protein--protein interaction in this membrane system, low concentrations of active NSAIDS effectively dissociate the bacteriorhodopsin lattice. These results suggest that the active NSAIDS studied here are able to partition deeply into the hydrocarbon region of the bilayer and interact with a membrane protein imbedded inside the bilayer. The prodrug sulindac per se is devoid of any significant membrane effects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7328581     DOI: 10.1021/jm00142a016

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.

Authors:  Luise Richter; Lisa-Marie Munter; Julia Ness; Peter W Hildebrand; Muralidhar Dasari; Stephanie Unterreitmeier; Bruno Bulic; Michael Beyermann; Ronald Gust; Bernd Reif; Sascha Weggen; Dieter Langosch; Gerd Multhaup
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

2.  Mixed micelles loaded with silybin-polyene phosphatidylcholine complex improve drug solubility.

Authors:  Rui-ling Duan; Xun Sun; Jie Liu; Tao Gong; Zhi-rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-12-20       Impact factor: 6.150

3.  Synthesis and biological evaluation of new benzo-thieno[3,2-d]pyrimidin-4-one sulphonamide thio-derivatives as potential selective cyclooxygenase-2 inhibitors.

Authors:  Mariarita Barone; Adriana Carol Eleonora Graziano; Agostino Marrazzo; Pietro Gemmellaro; Andrea Santagati; Venera Cardile
Journal:  Mol Divers       Date:  2013-04-26       Impact factor: 2.943

4.  Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability.

Authors:  Qunyou Tan; Shan Liu; Xueliang Chen; Mingjun Wu; Hong Wang; Huafeng Yin; Dan He; Huarong Xiong; Jingqing Zhang
Journal:  AAPS PharmSciTech       Date:  2012-03-28       Impact factor: 3.246

5.  A fast and reliable spectroscopic method for the determination of membrane--water partition coefficients of organic compounds.

Authors:  B de Castro; P Gameiro; J L Lima; C Matos; S Reis
Journal:  Lipids       Date:  2001-01       Impact factor: 1.880

6.  Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects.

Authors:  M J Fischer; J J Paulussen; D A Horbach; E P Roelofsen; J C van Miltenburg; N J de Mol; L H Janssen
Journal:  Inflamm Res       Date:  1995-02       Impact factor: 4.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.